Viswanath Devanarayan

Viswanath Devanarayan

UNVERIFIED PROFILE

Are you Viswanath Devanarayan?   Register this Author

Register author
Viswanath Devanarayan

Viswanath Devanarayan

Publications by authors named "Viswanath Devanarayan"

Are you Viswanath Devanarayan?   Register this Author

41Publications

1712Reads

27Profile Views

VGF in Cerebrospinal Fluid Combined With Conventional Biomarkers Enhances Prediction of Conversion From MCI to AD.

Alzheimer Dis Assoc Disord 2019 Jul 10. Epub 2019 Jul 10.

Charles River Laboratories, Horsham, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WAD.0000000000000328DOI Listing
July 2019

Report on the AAPS Immunogenicity Guidance Forum.

AAPS J 2019 Apr 16;21(4):55. Epub 2019 Apr 16.

Pharmaceutical Consultant, North Potomac, Maryland, 20878, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1208/s12248-019-0328-8
Publisher Site
http://dx.doi.org/10.1208/s12248-019-0328-8DOI Listing
April 2019

Identification of a Simple and Novel Cut-Point Based Cerebrospinal Fluid and MRI Signature for Predicting Alzheimer's Disease Progression that Reinforces the 2018 NIA-AA Research Framework.

J Alzheimers Dis 2019 ;68(2):537-550

Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Champaign, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-180905DOI Listing
January 2019

Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points.

AAPS J 2017 09 21;19(5):1487-1498. Epub 2017 Jul 21.

B2S Consulting, 6656 Flowstone Way, Indianapolis, Indiana, 46237, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1208/s12248-017-0107-3
Publisher Site
http://dx.doi.org/10.1208/s12248-017-0107-3DOI Listing
September 2017

Patient subgroup identification for clinical drug development.

Stat Med 2017 04 1;36(9):1414-1428. Epub 2017 Feb 1.

AbbVie, Inc., North Chicago, IL, U.S.A.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/sim.7236
Publisher Site
http://dx.doi.org/10.1002/sim.7236DOI Listing
April 2017

Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer.

J Clin Oncol 2015 Feb 5;33(5):433-41. Epub 2015 Jan 5.

Suresh S. Ramalingam and Taofeek K. Owonikoko, Winship Cancer Institute of Emory University, Atlanta, GA; Mikhail Shtivelband, Ironwood Cancer and Research Centers, Chandler, AZ; Ross A. Soo, National University Cancer Institute, National University Health System, Singapore, Singapore; Carlos H. Barrios, Pontifícia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre; José G.M. Segalla, Hospital Amaral Carvalho, Jau; Jose R. Pereira, Instituto Brasileiro de Cancerologia Toracica, Sao Paulo, Brazil; Anatoly Makhson, Moscow City Oncology Hospital No. 62; Vera A. Gorbunova, N.N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia; Kenneth B. Pittman, The Queen Elizabeth Hospital, Woodville, South Australia, Australia; Petr Kolman, Hospital Kyjov, Kyjov, Czech Republic; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing, MI; Chandra P. Belani, Penn State Hershey Cancer Institute, Hershey; Rita Axelrod, Thomas Jefferson University Hospital, Philadelphia, PA; Qin Qin, Jiang Qian, Evelyn M. McKeegan, Viswanath Devanarayan, Mark D. McKee, Justin L. Ricker, and Dawn M. Carlson, AbbVie, North Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478045PMC
February 2015

A PRIM approach to predictive-signature development for patient stratification.

Stat Med 2015 Jan 27;34(2):317-42. Epub 2014 Oct 27.

Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center New York, Roche TCRC, Inc., 430 East 29th Street, New York, NY 10016, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.6343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285951PMC
January 2015

Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease.

Alzheimer Dis Assoc Disord 2013 Jul-Sep;27(3):233-43

Department of Molecular and Integrative Physiology, University of Illinois, Urbana-Champaign 61801, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WAD.0b013e31826d597aDOI Listing
March 2014

A hidden Markov model-based algorithm for identifying tumour subtype using array CGH data.

BMC Genomics 2011 Dec 23;12 Suppl 5:S10. Epub 2011 Dec 23.

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-12-S5-S10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287492PMC
December 2011

Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease.

Dement Geriatr Cogn Dis Extra 2011 Jan 14;1(1):31-42. Epub 2011 Jan 14.

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000323417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199889PMC
January 2011

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.

Authors:
Leming Shi Gregory Campbell Wendell D Jones Fabien Campagne Zhining Wen Stephen J Walker Zhenqiang Su Tzu-Ming Chu Federico M Goodsaid Lajos Pusztai John D Shaughnessy André Oberthuer Russell S Thomas Richard S Paules Mark Fielden Bart Barlogie Weijie Chen Pan Du Matthias Fischer Cesare Furlanello Brandon D Gallas Xijin Ge Dalila B Megherbi W Fraser Symmans May D Wang John Zhang Hans Bitter Benedikt Brors Pierre R Bushel Max Bylesjo Minjun Chen Jie Cheng Jing Cheng Jeff Chou Timothy S Davison Mauro Delorenzi Youping Deng Viswanath Devanarayan David J Dix Joaquin Dopazo Kevin C Dorff Fathi Elloumi Jianqing Fan Shicai Fan Xiaohui Fan Hong Fang Nina Gonzaludo Kenneth R Hess Huixiao Hong Jun Huan Rafael A Irizarry Richard Judson Dilafruz Juraeva Samir Lababidi Christophe G Lambert Li Li Yanen Li Zhen Li Simon M Lin Guozhen Liu Edward K Lobenhofer Jun Luo Wen Luo Matthew N McCall Yuri Nikolsky Gene A Pennello Roger G Perkins Reena Philip Vlad Popovici Nathan D Price Feng Qian Andreas Scherer Tieliu Shi Weiwei Shi Jaeyun Sung Danielle Thierry-Mieg Jean Thierry-Mieg Venkata Thodima Johan Trygg Lakshmi Vishnuvajjala Sue Jane Wang Jianping Wu Yichao Wu Qian Xie Waleed A Yousef Liang Zhang Xuegong Zhang Sheng Zhong Yiming Zhou Sheng Zhu Dhivya Arasappan Wenjun Bao Anne Bergstrom Lucas Frank Berthold Richard J Brennan Andreas Buness Jennifer G Catalano Chang Chang Rong Chen Yiyu Cheng Jian Cui Wendy Czika Francesca Demichelis Xutao Deng Damir Dosymbekov Roland Eils Yang Feng Jennifer Fostel Stephanie Fulmer-Smentek James C Fuscoe Laurent Gatto Weigong Ge Darlene R Goldstein Li Guo Donald N Halbert Jing Han Stephen C Harris Christos Hatzis Damir Herman Jianping Huang Roderick V Jensen Rui Jiang Charles D Johnson Giuseppe Jurman Yvonne Kahlert Sadik A Khuder Matthias Kohl Jianying Li Li Li Menglong Li Quan-Zhen Li Shao Li Zhiguang Li Jie Liu Ying Liu Zhichao Liu Lu Meng Manuel Madera Francisco Martinez-Murillo Ignacio Medina Joseph Meehan Kelci Miclaus Richard A Moffitt David Montaner Piali Mukherjee George J Mulligan Padraic Neville Tatiana Nikolskaya Baitang Ning Grier P Page Joel Parker R Mitchell Parry Xuejun Peng Ron L Peterson John H Phan Brian Quanz Yi Ren Samantha Riccadonna Alan H Roter Frank W Samuelson Martin M Schumacher Joseph D Shambaugh Qiang Shi Richard Shippy Shengzhu Si Aaron Smalter Christos Sotiriou Mat Soukup Frank Staedtler Guido Steiner Todd H Stokes Qinglan Sun Pei-Yi Tan Rong Tang Zivana Tezak Brett Thorn Marina Tsyganova Yaron Turpaz Silvia C Vega Roberto Visintainer Juergen von Frese Charles Wang Eric Wang Junwei Wang Wei Wang Frank Westermann James C Willey Matthew Woods Shujian Wu Nianqing Xiao Joshua Xu Lei Xu Lun Yang Xiao Zeng Jialu Zhang Li Zhang Min Zhang Chen Zhao Raj K Puri Uwe Scherf Weida Tong Russell D Wolfinger

Nat Biotechnol 2010 Aug 30;28(8):827-38. Epub 2010 Jul 30.

National Center for Toxicological Research, US Food and Drug Administration, Jefferson, Arkansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt.1665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315840PMC
August 2010

Confirmatory reanalysis of incurred bioanalytical samples.

AAPS J 2007 Oct 5;9(3):E336-43. Epub 2007 Oct 5.

Department of Bioanalytical Sciences, Prevalere Life Sciences Inc., Whitesboro, NY 13492, USA.

View Article

Download full-text PDF

Source
http://www.springerlink.com/index/10.1208/aapsj0903040
Publisher Site
http://dx.doi.org/10.1208/aapsj0903040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751485PMC
October 2007

Optimization of analytical and pre-analytical variables associated with an ex vivo cytokine secretion assay.

J Pharm Biomed Anal 2006 Apr;41(1):189-95

Laboratory for Experimental Medicine, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2005.10.013DOI Listing
April 2006

Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum.

J Pharm Biomed Anal 2005 Jan;36(5):1037-44

Laboratory for Experimental Medicine, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2004.05.024DOI Listing
January 2005

A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.

Int J Cancer 2002 Jan;97(2):149-56

Eli Lilly and Company, Department of Cancer Research, Lilly Corporate Center, drop code 0424, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.1590DOI Listing
January 2002